Selected article for: "cerebrospinal fluid and clinical entity"

Author: Krett, Jonathan D.; Jewett, Gordon A.E.; Elton-Lacasse, Charissa; Fonseca, Kevin; Hahn, Christopher; Au, Selena; Koch, Marcus W.
Title: Hemorrhagic encephalopathy associated with COVID-19
  • Cord-id: ey30t0hr
  • Document date: 2020_7_14
  • ID: ey30t0hr
    Snippet: The mechanisms for neurological complications of COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), are not yet well understood. We present a critically ill man with a COVID-19-associated hemorrhagic encephalopathy. SARS-CoV-2 RNA was not detected in cerebrospinal fluid (CSF) or blood. CSF analyses suggested dysregulation of pro-inflammatory cytokine pathways, particularly tumor necrosis factor-α and interleukin-6, consistent with a cytokine release sy
    Document: The mechanisms for neurological complications of COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), are not yet well understood. We present a critically ill man with a COVID-19-associated hemorrhagic encephalopathy. SARS-CoV-2 RNA was not detected in cerebrospinal fluid (CSF) or blood. CSF analyses suggested dysregulation of pro-inflammatory cytokine pathways, particularly tumor necrosis factor-α and interleukin-6, consistent with a cytokine release syndrome. The patient gradually recovered with supportive care and neurological rehabilitation. Awareness of this clinical entity may facilitate the identification of patients with a potentially remediable cause of encephalopathy in COVID-19.

    Search related documents:
    Co phrase search for related documents